Roundhill Glp-1 & Weight Loss ETF OZEM

Medalist Rating as of | See Roundhill Investment Hub

Morningstar’s Analysis OZEM

Will OZEM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Roundhill GLP-1 & Weight Loss ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings OZEM

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 65.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS ADR

12.81 8M
Healthcare

Eli Lilly and Co

12.45 8M
Healthcare

Pfizer Inc

6.18 4M
Healthcare

Kailera Therapeutics Inc

5.94 4M
Healthcare

Viking Therapeutics Inc

5.81 4M
Healthcare

CSPC Pharmaceutical Group Ltd

5.79 4M
Healthcare

Ascletis Pharma Inc Ordinary Shares

4.29 3M
Healthcare

Chugai Pharmaceutical Co Ltd

4.24 3M
Healthcare

Amgen Inc

3.78 2M
Healthcare

Zealand Pharma AS

3.78 2M
Healthcare

Sponsor Center